Bill Text: NY S00504 | 2023-2024 | General Assembly | Amended

---

Bill Title: Prohibits cost sharing for insulin; provides that an insured shall not be subject to a deductible, copayment, coinsurance or any other cost sharing requirement for the purchase of insulin.

Spectrum: Partisan Bill (Democrat 9-0)

Status: (Engrossed) 2024-01-30 - referred to insurance [S00504 Detail]

Download: New_York-2023-S00504-Amended.html

---

                STATE OF NEW YORK
        ________________________________________________________________________

                                         504--A
            Cal. No. 91

                               2023-2024 Regular Sessions

                    IN SENATE

                                     January 4, 2023
                                       ___________

        Introduced by Sens. RIVERA, ADDABBO, COONEY, LIU, MARTINEZ -- read twice
          and ordered printed, and when printed to be committed to the Committee
          on  Insurance  -- recommitted to the Committee on Insurance in accord-
          ance with Senate Rule 6,  sec.  8  --  reported  favorably  from  said
          committee,  ordered  to  first  and  second report, ordered to a third
          reading, amended and ordered reprinted, retaining  its  place  in  the
          order of third reading

        AN ACT to amend the insurance law, in relation to prohibiting cost shar-
          ing for insulin

          The  People of the State of New York, represented in Senate and Assem-
        bly, do enact as follows:

     1    Section 1. Subparagraph (B) of paragraph 15-a  of  subsection  (i)  of
     2  section  3216  of the insurance law, as amended by section 1 of part DDD
     3  of chapter 56 of the laws of 2020, is amended to read as follows:
     4    (B) Such coverage may be subject to annual deductibles and coinsurance
     5  as may be deemed appropriate by the superintendent and as are consistent
     6  with those  established  for  other  benefits  within  a  given  policy;
     7  provided  however, [the total amount] that [a covered person is required
     8  to pay out of pocket for] covered prescription insulin drugs  shall  [be
     9  capped  at  an  amount  not to exceed one hundred dollars per thirty-day
    10  supply, regardless of the amount or type of insulin needed to fill  such
    11  covered  person's  prescription  and regardless of the insured's] not be
    12  subject to a deductible, copayment, coinsurance or any other cost  shar-
    13  ing requirement.
    14    § 2. Subparagraph (B) of paragraph 7 of subsection (k) of section 3221
    15  of  the insurance law, as amended by section 2 of part DDD of chapter 56
    16  of the laws of 2020, is amended to read as follows:
    17    (B) Such coverage may be subject to annual deductibles and coinsurance
    18  as may be deemed appropriate by the superintendent and as are consistent
    19  with those  established  for  other  benefits  within  a  given  policy;
    20  provided  however, [the total amount] that [a covered person is required

         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD02649-04-4
        S. 504--A                           2

     1  to pay out of pocket for] covered prescription insulin drugs  shall  [be
     2  capped  at  an  amount  not to exceed one hundred dollars per thirty-day
     3  supply, regardless of the amount or type of insulin needed to fill  such
     4  covered  person's  prescription  and regardless of the insured's] not be
     5  subject to a deductible, copayment, coinsurance or any other cost  shar-
     6  ing requirement.
     7    §  3.  Paragraph  2 of subsection (u) of section 4303 of the insurance
     8  law, as amended by section 3 of part DDD of chapter 56 of  the  laws  of
     9  2020, is amended to read as follows:
    10    (2) Such coverage may be subject to annual deductibles and coinsurance
    11  as may be deemed appropriate by the superintendent and as are consistent
    12  with  those  established  for  other  benefits  within  a  given policy;
    13  provided however, [the total amount] that [a covered person is  required
    14  to  pay  out of pocket for] covered prescription insulin drugs shall [be
    15  capped at an amount not to exceed one  hundred  dollars  per  thirty-day
    16  supply,  regardless of the amount or type of insulin needed to fill such
    17  covered person's prescription and regardless of the  insured's]  not  be
    18  subject  to a deductible, copayment, coinsurance or any other cost shar-
    19  ing requirement.
    20    § 4. This act shall take effect January 1, 2025 and shall apply to any
    21  policy or contract issued, renewed, modified, altered, or amended on  or
    22  after such date.